Cell cryopreservation involves freezing cells at extremely low temperatures (-80°C or below) to preserve them for long periods of time. The process allows cells to be stored and thawed as needed for applications like maintaining cell/tissue cultures, stem cell therapeutic developments, and biobanking. It offers numerous advantages compared to the traditional approach of short-term storage at 4°C. The technique allows indefinite storage of cells and tissues without deteriorating viability and functionality. This provides flexibility to researchers and industries to retrieve biological samples as per requirement.
The global cell cryopreservation market is estimated to be valued at US$ 263.58 billion in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period of 2024 to 2031.
The increasing adoption in the pharmaceutical and biotechnology industries is a major factor driving market growth. Manufacturers in these industries widely rely on cell and tissue Cell Cryopreservation Market Size techniques to preserve biological products for quality check, research, and development purposes. Besides industrial usage, rising application in stem cell therapeutics, regenerative medicine, and organ transplantations is also propelling demand.
Key Takeaways
Key players operating in the cell cryopreservation market are BASF, DSM, Kemin Industries, Naturex, Synthite Industries, Aarkay Food Products, Dohler, Sensient Technologies, Vitablend. These players are adopting strategies like partnerships, collaborations, and new product launches to sustain competition.
The global market presents ample opportunities for players in the form of untapped regions. Emerging economies in Asia Pacific and Latin America with growing stem cell research and regenerative medicine sectors are lucrative for investments. North America and Europe currently dominate the market but are anticipated to witness relatively slower growth compared to developing regions.
Globally, companies are expanding their production and R&D facilities across multiple regions. They are also entering into long-term supply contracts and collaborations with end-user industries and academic institutions to ensure a strong global footprint. Partnerships with local players help gain familiarity with regional market dynamics and regulations.
Market Drivers
Growing stem cell research and clinical trials: Increasing government funding and initiatives to develop stem cell therapeutics are driving the use of cell cryopreservation techniques in academic and clinical research. Many therapies in clinical trials rely on cryopreserved stem cells.
Rising biopharma outsourcing: Pharmaceutical manufacturers are outsourcing more production processes including cell banking to contract service providers. This is increasing the commercial demand for scalable cryopreservation equipment and consumables.
Market Restrain
High costs associated: Cryopreservation equipment, media, and protocols require substantial investments. The overall process adds to product costs. This can restrain widespread adoption, especially in price-sensitive developing markets.
Challenges in optimizing protocols: Variations exist across cell types in terms of optimal cooling and warming rates, cryoprotectants, and handling. Standardizing protocols needs extensive research which slows market evolution.
Segment Analysis
The global cell cryopreservation market is segmented based on type, technology, application, and end-user. Within type, stem cells is expected to be the dominant sub-segment during the forecast period owing to rising stem cell research activities and growing prevalence of cancer and genetic disorders. The technology segment is divided into slow freezing, vitrification, and controlled rate freezing. The vitrification technology sub-segment holds a significant share in the market and is expected to maintain its dominance through the forecast period. This is attributed to vitrification's low maintenance cost and ability to eliminate ice crystal formation, thereby preventing cell damage.
Global Analysis
The Asia Pacific region is anticipated to witness the fastest growth in the cell cryopreservation market during the forecast period. This growth is attributed to factors such as rising research funding for stem cell research, increasing investment from market players, and growing awareness related to stem cell and tissue preservation in emerging countries of the region such as China, India, and South Korea. North America dominated the global market in 2024 and is expected to continue its stronghold during the forecast period. This dominance is owing to well-developed healthcare infrastructure, rising research in regenerative medicine and tissue engineering, and growing biobanking activities in the region.
Gets More Insights on, Cell Cryopreservation Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
0 comment